莱美药业：第五届监事会第三十九次会议决议公告

Group 1 - The core point of the article is that Laimei Pharmaceutical announced the approval of multiple proposals during the 39th meeting of its fifth supervisory board [2] Group 2 - The announcement includes the approval of the agenda and its summary [2]